Novo Nordisk Joins Fight With HHS Over Drug Price Talks
Novo Nordisk Inc. joined other Big Pharma companies on Friday suing over the Inflation Reduction Act's Medicare drug price negotiation provision, calling the program "extreme and unprecedented" in a lawsuit filed...To view the full article, register now.
Already a subscriber? Click here to view full article